Acura Pharmaceuticals Inc (ACUR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-1995 | 06-1995 | 03-1995 | 12-1994 | 09-1994 | |
| Sales | 4,347 | 4,883 | 6,873 | 5,566 | 5,579 |
| Cost of Goods | 12,868 | 3,705 | 5,114 | 17,006 | 4,578 |
| Gross Profit | 3,236 | 1,178 | 1,759 | 1,598 | 1,001 |
| Operating Expenses | 5,844 | 2,299 | 1,808 | -968 | 5,362 |
| Operating Income | -13,497 | -416 | 65 | -10,466 | -3,783 |
| Interest Expense | 862 | 211 | 226 | 140 | 226 |
| Other Income | 15,952 | 4 | 4,188 | 7,610 | 3,038 |
| Pre-tax Income | 1,593 | -623 | 4,027 | -2,996 | -971 |
| Income Tax | 296 | 0 | 296 | 0 | 0 |
| Net Income Continuous | -1,811 | -623 | 3,731 | -2,987 | -971 |
| Net Income | $-1,811 | $-623 | $3,731 | $-2,987 | $-971 |
| EPS Basic Total Ops | -11.50 | -4.00 | 24.00 | -20.50 | -7.00 |
| EPS Basic Continuous Ops | -11.73 | -3.84 | 23.99 | -20.50 | -6.83 |
| EPS Diluted Total Ops | -11.50 | -4.00 | 24.00 | -20.50 | -7.00 |
| EPS Diluted Continuous Ops | -11.73 | -3.84 | 23.99 | -20.50 | -6.83 |
| EBITDA(a) | $-13,497 | $-416 | $65 | $-10,466 | $-3,783 |